ASH 2020: Dr. Alexey Danilov Discusses Chronic Lymphocytic Leukemia (CLL) Patients Participating in Clinical Trials During the COVID-19 Pandemic ASH 2020: Dr. Alexey Danilov Discusses Chronic Lymphocytic Leukemia (CLL) Patients Participating in Clinical Trials During the COVID-19 Pandemic.... February 25, 20212020 ConferencesBy Brad Hedrick
It’s Clinical Trials Awareness Week! The CLL Society partners with the nonprofit Coalition for Clinical Trials Awareness to increase trial awareness and participation for CLL... May 18, 2020News about Clinical TrialsBy Brad Hedrick
FDA places a partial hold on all venetoclax clinical trials for multiple myeloma (MM) patients The U.S. Food and Drug Administration (FDA) put the partial hold on all MM trials when they did a pre-planned... March 20, 2019Business, Finances, Insurance & RegulatoryBy Brad Hedrick
ASH 2018: Dr. Furman on the evolving role of clinical trials in CLL ASH, short for the American Society of Hematology Annual Meeting and Exposition, is the showcase for the latest and best... January 28, 20192018 ConferencesBy Brad Hedrick
ASCO 2018: Dr. Matt Davids on CLL Clinical Trials Open at Dana Farber Cancer Institute In following up on our interview about the CLL research presented at ASCO 2018, Dr. Matt Davids from Dana Farber... January 22, 20192018 ConferencesBy Brad Hedrick
Clinical Trials and our Clinical Trial Banner You may notice a new feature on the CLL Society website, a Clinical Trial Banner on our home page. As many... October 21, 2018News about Clinical TrialsBy Brad Hedrick
How to Succeed in Modernizing Clinical Trials Clinical trials are the lifeblood for those of us with CLL and the only way that our treatment has improved. But... February 28, 2017News about Clinical TrialsBy Todd Dennison
Vice President Biden Announces New Steps to Improve Clinical Trials Essential to Advancing the Cancer Moonshot September 16, 2016 - Vice President Joe Biden announced a series of new steps focused on increasing access to information... September 20, 2016Business, Finances, Insurance & RegulatoryBy Todd Dennison
Dr. William Wierda on Clinical Trials in CLL (chronic lymphocytic leukemia) Dr. Bill Wierda, the head of the CLL program at MD Anderson Cancer Center, discusses the advantages for patients of... June 13, 2016The BasicsBy Todd Dennison
Clinical Trials: A Two Person Perspective In mid-year 2014, Teresa Altemeyer and Paul Zamecnik didn’t know each other, but were independently evaluating whether or not to... June 9, 2016The Patient PerspectiveBy clladm1n
